IL6 and atherosclerosis: In addition, NaVO3-mediated IL-6 enhancement and SM22α reduction in the atherosclerotic lesions were suppressed by NAC in a dose-dependent manner (Figure 6H–J), indicating that NaVO3 triggers ROS-meditated IL-6 production to induce atherosclerosis.